Table 7.

Esophageal cancer pathologic response to neoadjuvant HFR in similar studies.

Study	Patient Number	Complete Response	Near Complete Response
Jiang et al. (39)	20	11 (55%)	–
Walsh et al. (19)	52	13 (25%)	–
Lyu et al. (18)	42	14 (33.3%)	–
This study	32	17 (53.1%)	6 (18.8%)